PhD CPsychol AFBPsS
Personal Chair
- About
-
- Email Address
- s.maclennan@abdn.ac.uk
- Telephone Number
- +44 (0)1224 438125
- Office Address
Academic Urology Unit Health Sciences Building (2nd Floor) University of Aberdeen Foresterhill Aberdeen AB25 2ZD
- School/Department
- School of Medicine, Medical Sciences and Nutrition
Biography
I am a psychosocial oncologist and a health psychologist with expertise in qualitative research methodology. I pursue an interdisciplinary approach building multi-stakeholder working in cancer care and have established global partnerships of academics, patients, non-profit organisations, professional organisations and policy makers.
Aberdeen Applied Cancer Research Group (ICANTREAT):
I lead the Aberdeen Applied Cancer Research Group (ICANTREAT)
The group's research strategy focuses on understanding the impact of cancer and treatment on individual’s lives and methods for involving different stakeholder groups, particularly patients, in the design and delivery of care.
I am Deputy Director of the Academic Urology Unit, Director of Operations for UCAN (Urological CANcer charity) and hold an honorary contract with NHS Grampian. I am an Honorary Research Fellow, Birkbeck University of London. I am a Chartered Psychologist and Associate Fellow of the British Psychological Society, and a registered health psychologist (Health & Care Professions Council).
Current projects include:
Stakeholder engagement in the design and implementation of cancer care:
ICANBE – Managing Fear of Cancer Recurrence
EVOLVE – Giving cancer patients a meaningful voice within the design and delivery of clinical practice guidelines
ICANTREATNEPAL / ICANTREATINDIA – Increasing participation in cancer screening and treatment in India & Nepal (International Global Health Network)PARTNER –Men’s prostate cancer treatment preferences
OPTIMA – Optimal treatments for patients with solid tumours in Europe through AIPIONEER – Enhancing prostate cancer diagnosis and treatment through the power of big data in Europe
Example of Impact:
I am to keen to supervise PhD students interested in working in cancer survivorship and supportive care.
Memberships and Affiliations
- Internal Memberships
-
University Committees:
Chair - Institute of Applied Health Sciences (IAHS) Research Strategy Group
Chair - Institute of Applied Health Sciences (IAHS) Health, Safety & Well-being Committee - External Memberships
-
Current External Membership:
Member - European Cancer Organisation Steering Committee for Survivorship and Quality of Life (2021 onwards)
Member - European Cancer Organisation Survivorship Focused Topic Network (2021 onwards)
Member - European Cancer Organisation Workforce Focused Topic Network (2021 onwards)
Member – Executive Committee, British Psychosocial Oncology Society (2016 - onwards)
Member – National Cancer Research Institute –Living With and Beyond Cancer Late Effects Workstream (2019 onwards)
Member – Patient Advocacy Group, European Association of Urologists (2018 - onwards)
Member – Breast Cancer Now, Grants Award Committee (2018 – onwards)
Member – ESRC Peer Review College (2017 – onwards)Previous External Membership:
Member – MRC Strategic Skills Panel (2013 - 2017)
Member – Grants Award Panel, Carnegie Trust
Member – Executive Committee, Division of Health Psychology Scotland (2016 - 2017)
External Examiner (MSc) MSc Health Psychology, University of Westminster (2008 - 2011)
Member - BPS working party on ‘Work and Health’
Elected Member – Training Committee, Division of Health Psychology (2006 - 2008)
Elected Member - Executive Committee, Division of Health Psychology (2006 – 2008)
Assessor - Board of Assessors, Division of Health Psychology (2002 - 2008)
Examiner – Paper 4 (Health Psychology), Qualifying Examination (2002 – 2012)
Member - BPS working party on ‘Psychological Debriefing’(2001 - 2002)
Latest Publications
CATHETER II, a randomised controlled trial comparing the clinical and cost effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long term catheters
BMJ OpenContributions to Journals: ArticlesWeb-based interventions for fear of cancer recurrence: a scoping review with a focus on suggestions for the development and evaluation of future interventions
PloS ONE, vol. 19, no. 11, e0312769Contributions to Journals: ArticlesPatient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial
RCOG World Congress 2024Contributions to Conferences: PostersPatient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial
The International Continence SocietyContributions to Conferences: PostersRCT comparing the clinical and cost effectiveness of various catheter washout policies
RCOG World Congress 2024Contributions to Conferences: Posters
- Research
-
Research Overview
I am a psychosocial oncologist and a health psychologist with expertise in qualitative research methodology. I pursue an interdisciplinary approach building multi-stakeholder working in cancer care and have established global partnerships of academics, patients, non-profit organisations, professional organisations and policy makers. Key to this is an understanding of processes within the delivery of routine clinical care. My research expertise includes process evaluation.
My research strategy focuses on understanding the impact of cancer and treatment on individual’s lives and methods for involving different stakeholder groups, particularly patients, in the design and delivery of care.
Research Areas
Applied Health Sciences
Nutrition and Health
Psychology
Research Specialisms
- Health and Social Care
- Applied Psychology
- Health Psychology
- Oncology
Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is HESA open data, published under the Creative Commons Attribution 4.0 International licence.
Current Research
I currently have eleven funded projects (total awards £5,644,624) across three themes:
Stakeholder engagement in the design and implementation of cancer care (Developed and Lead Projects):
- ICANBE – Fear of Cancer Recurrence
- EVOLVE – Giving cancer patient’s a meaningful voice within the design and delivery of clinical practice guidelines across Europe
- PIONEER – Enhancing prostate cancer diagnosis and treatment through the power of big data in Europe; €12,000,000 EU grant (Lead for Aberdeen)
- ICANTREAT – Increasing participation in breast cancer screening and treatment in Nepal and in Uganda; screening and treatment inequalities in India (International Global Health Research Group)
The design and implementation of better cancer care (Co-applicant):
- OPTIMA – Optimal treatments for patients with solid tumours in Europe through AI
- PARTNER – Men’s prostate cancer treatment preferences
- ICAN – Improving understanding of Urological cancer (Cancer Research Group)
- RCOS – Kidney Cancer core outcome set
The design and delivery of care and after care - Urology and other long-term conditions (Co-applicant)
- SIMS LTFU – Surgical management of female stress urinary incontinence
- CATHETER II – Understanding the patient experience of care; embedded qualitative study within a clinical trial to look at Catheter washout policies
- PACFIND – Patient-centred care for Fibromyalgia
Funding and Grants
£1,185,670 Arthritis UK (2019 – 2024). Patient-centred Care for Fibromyalgia: New pathway Design (PACFIND). MacFarlane, G [PI], Maclennan SJ et al. [co-applicants]
£24,537 NHS Grampian. (2018-2019). Achieving Self-Directed Integrated Cancer Aftercare (ASICA): developing digitally supported cancer aftercare to achieve high quality, equitable care for diverse populations. Murchie, P [PI], Maclennan SJ et al. [co-applicants]
£9,805 GCRF-IPPF3 (2018). Increasing participation in breast cancer screening and treatment within Manipal, India (CANTREAT). MacLennan, SJ., & Poobalan, A.
£5,341,011 EU IMI (2018-2023). Prostate Cancer Diagnosis and TreatmeNt Enhancement through the Power of Big Data in EuRope – PIONEER (2018 – 2023). PIONEER Consortium – MacLennan SJ – lead applicant for University of Aberdeen group.
£2,271,424 NIHR HTA (2018-2023) Randomised Controlled Trial CompAring THE Clinical And CosT- Effectiveness Of Various Washout Policies Versus No Washout Policy In Preventing Catheter Associated Complications In Adults Living With Long-Term Catheters (CATHETER II Study). Abdel-Fattah, M. [PI], Maclennan SJ et al. [co-applicants]
£175,000 NHS Grampian Endowments (via UCAN) (2018-2021). EVOLVE: Giving Patients a Meaningful Voice in the Design and Delivery of Care. S J MacLennan
£50,000 European Association of Urology (2017-2018). Review of Renal Cell Carcinoma: Muscle-invasive & Metastatic Bladder Cancer (Lymph node Dissection) & Penile Cancer. N’Dow, J., & MacLennan, S.J.
£123,357 UCAN (2017- 2019). Meeting the Needs of Patients: Developing Core outcome Sets for Urological Cancer. MacLennan, S.J.
€1,070 EU COST action STSM-IS1211-35195 (2016). Cancer and Work Participation: Research visit to Dr Angela de Boer, Coronel Institute for Occupational Health, Academic Medical Centre, Amsterdam. MacLennan, SJ.
£11,548 NHS Grampian Endowments Award (2015 – 2016). Understanding the hard choices made by working women with breast cancer between treatment compliance and working on: clinical vs economic survival. Improving the Role of the NHS in Grampian. MacLennan SJ., Cox T., N’Dow, J & Heys, S.
£750 Santander Mobility Award (2015), University of Aberdeen. Developing the METIS Collaboration: Cancer Survivorship, Work & Working Life. MacLennan SJ.
£29,500 ESRC (2014 – 2017) Social Science Perspectives on the Working Lives of Those with Cancer: Psychosocial, Organisational and Economic Perspectives. Cox, T., MacLennan, SJ., Hassard, J., & Brown, H.
£25,000 Birkbeck University of London (2014) The Metis Collaboration: Cancer Survivorship, Work & Working Life. MacLennan, SJ.
£109,646 Macmillan Cancer Support (2013 – 2015) Cancer Survivorship: The Patient Journey, Work & Working Life. MacLennan, SJ., Cox, T., & N’Dow, J.
£1,426,755 Health Technology Assessment Programme (HTA) (2013 – 2017)Therapeutic Interventions for Stones of the Ureter (TISU): a multicentre randomised controlled trial of extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic retrieval, for ureteric stones. (McClinton,S., N’Dow, J., MacLennan, GS., Kilonzo, M., Keeley, F., Anson, K., Clark, C., Pickard, R., Norrie, J., MacLennan, SJ., Thomas, R., Starr, K., Burgess, N., Lam, T., Kurban, L.)
£292,253 Health Technology Assessment Programme (HTA) (2012 – 2015) Ablative therapy for men with localised prostate cancer (Ramsay, C., Pickard, R., Vale, L., Lam, T., Mowatt, G., MacLennan, SJ., Rushton, S., N’Dow, J., Merseburger, A., Shirley, M., & Heidenreich, A. )
£176,903 Cancer Research Aberdeen & North East Scotland (CRANES) (2012 – 2015) Development of core outcomes for surgical management of localised prostate cancer to support decision-making by patients, clinicians and policy makers (Lam, T., N’Dow, J., MacLennan, SJ., Ramsay, C., & Campbell, M)
£24,680 The Prostate Cancer Charity Scotland (2011 – 2012) Support groups for men who have prostate cancer, their families and friends: identifying best practice models (MacLennan, SJ., Skea, Z, N’Dow, J & McCann, S)
£14,042 Scottish Cancer Research Network (2011 – 2012) Information for choice in urological cancer: What people need, prefer and use (MacLennan, SJ., & Skea, Z)
£10,317 Scottish Cancer Research Network (2010 – 2011) Delivering Peer Support Interventions in Urological Cancer (Employing a research nurse) (MacLennan, SJ., & N’Dow, J)
£150,700UCAN (Urological Cancer Charity) (2008 – 2013) Addressing the gaps in evidence for treatment of urological cancers (Employing a systematic reviewer) (N’Dow, J., MacLennan, SJ., & Imamura, M)
£165,975 The Scottish Government – CSO (2009 – 2012) Postdoctoral Training Fellowship in Health Services and Health of Public Research – The Acceptability and Usefulness of a Trial Participation Decision Aid: A Mixed Methods Study of Patients and Clinicians in the UK (Schumm, K., Campbell, M., Ramsay, C., N’Dow, J., Skea, Z., & MacLennan, SJ)
£245,482 UCAN (Urological Cancer Charity) (2009 – 2013) Information needs of those living with urological cancer (MacLennan, SJ)
£147,000 Macmillan in partnership with UCAN (2009 – 2012) Making life better for those living with urological cancer (MacLennan, SJ)
Datasets
-
Health status and associated factors of middle-aged and older adult cancer survivors in India: results from the Longitudinal Ageing Study in India
Abstract Background The number of persons who have survived cancer has been increasing in India as elsewhere due to advances in detection and treatment of this disease. However, evidence on the standardised number of cancer survivors, their characteristics and their complex health challenges on a national level does not exist due to data limitations. This study, therefore, examines the profile of cancer survivors and their health status using the recently released Longitudinal Ageing Study in India (LASI) survey data. Methods LASI wave 1 is a cross-sectional nationally representative survey of 65,562 middle and older adults aged 45 and above. We first calculated the socioeconomic, demographic and geographical characteristics of cancer survivors (per 100,000 population). We later estimated the adjusted odds of poor health, sleep problems, depressive symptoms, activities of living limitations (ADL and IADL), and hospitalisation of cancer survivors using multivariable logistic regression analysis. Results According to LASI estimates, there were 2.1 million cancer survivors in India (95% CI 1.8 million to 2.6 million) in 2017–18. Overall, 440 cancer survivors have been identified in this study, with considerable state variations. The number of cancer survivors per 1,00,000 population was relatively more in non-indigenous groups, people with a history of cancer in their families, those who worked earlier but currently not working and those in the richest quintile categories. As compared to those who never had cancer, the cancer survivors are at higher risk of hospitalisation (adjusted odds ratio (aOR) = 2.61 CI 1.86, 3.67), poor self-rated health (aOR = 3.77, CI 2.55, 5.54), depressive symptoms (aOR = 1.53, CI 1.41, 2.05) and sleep problems (aOR = 2.29, CI 1.50, 3.47). They also reported higher ADL (aOR = 1.61, CI 1.11, 2.34) and IADL (aOR = 1.49, CI 1.07, 2.07) limitations. Cancer survivors who had their cancer diagnosis in the past 2 years or a cancer-related treatment in the past 2 years have significantly higher odds of poor health status than middle-aged and older adults without a cancer history. Conclusion Middle-aged and older cancer survivors, particularly those who underwent cancer diagnosis or treatment in the past 2 years, are at a significantly higher risk of experiencing poor self-reported health and other health challenges, suggesting the need for an integrated healthcare approach.- DOI
- 10.6084/m9.figshare.c.6262030
- Publisher
- Figshare
- Links
- Date Made Available
- 23 November 2024
- Related Research Outputs
- Contributors
- Guntupalli, A. M. (Creator), Selvamani, Y. (Creator), Maclennan, S. J. (Creator), Dilip, T. R. (Creator)
-
Data from: Health status and associated factors of middle-aged and older adult cancer survivors in India: results from the Longitudinal Ageing Study in India
Abstract Background The number of persons who have survived cancer has been increasing in India as elsewhere due to advances in detection and treatment of this disease. However, evidence on the standardised number of cancer survivors, their characteristics and their complex health challenges on a national level does not exist due to data limitations. This study, therefore, examines the profile of cancer survivors and their health status using the recently released Longitudinal Ageing Study in India (LASI) survey data. Methods LASI wave 1 is a cross-sectional nationally representative survey of 65,562 middle and older adults aged 45 and above. We first calculated the socioeconomic, demographic and geographical characteristics of cancer survivors (per 100,000 population). We later estimated the adjusted odds of poor health, sleep problems, depressive symptoms, activities of living limitations (ADL and IADL), and hospitalisation of cancer survivors using multivariable logistic regression analysis. Results According to LASI estimates, there were 2.1 million cancer survivors in India (95% CI 1.8 million to 2.6 million) in 2017–18. Overall, 440 cancer survivors have been identified in this study, with considerable state variations. The number of cancer survivors per 1,00,000 population was relatively more in non-indigenous groups, people with a history of cancer in their families, those who worked earlier but currently not working and those in the richest quintile categories. As compared to those who never had cancer, the cancer survivors are at higher risk of hospitalisation (adjusted odds ratio (aOR) = 2.61 CI 1.86, 3.67), poor self-rated health (aOR = 3.77, CI 2.55, 5.54), depressive symptoms (aOR = 1.53, CI 1.41, 2.05) and sleep problems (aOR = 2.29, CI 1.50, 3.47). They also reported higher ADL (aOR = 1.61, CI 1.11, 2.34) and IADL (aOR = 1.49, CI 1.07, 2.07) limitations. Cancer survivors who had their cancer diagnosis in the past 2 years or a cancer-related treatment in the past 2 years have significantly higher odds of poor health status than middle-aged and older adults without a cancer history. Conclusion Middle-aged and older cancer survivors, particularly those who underwent cancer diagnosis or treatment in the past 2 years, are at a significantly higher risk of experiencing poor self-reported health and other health challenges, suggesting the need for an integrated healthcare approach.- DOI
- 10.6084/m9.figshare.c.6262030.v1
- Publisher
- Figshare
- Links
- Date Made Available
- 23 November 2024
- Related Research Outputs
- Contributors
- Guntupalli, A. M. (Creator), Selvamani, Y. (Creator), Maclennan, S. J. (Creator), Dilip, T. R. (Creator)
-
Data From Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review
- DOI
- 10.1186/s43058-023-00498-0
- Publisher
- University of Aberdeen
- Links
-
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM1_ESM.docx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM2_ESM.docx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM3_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM4_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM5_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM6_ESM.xlsx
- Date Made Available
- 18 December 2023
- Related Research Outputs
- Contributors
- Dunsmore, J. (Creator), Duncan, E. (Creator), MacLennan, S. (Creator), N'Dow, J. (Creator), MacLennan, S. (Creator)
-
Data From Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review
- DOI
- 10.1186/s43058-023-00498-0
- Publisher
- University of Aberdeen
- Links
-
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM1_ESM.docx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM2_ESM.docx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM3_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM4_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM5_ESM.xlsx
- https://static-content.springer.com/esm/art%3A10.1186%2Fs43058-023-00498-0/MediaObjects/43058_2023_498_MOESM6_ESM.xlsx
- Date Made Available
- 18 December 2023
- Related Research Outputs
- Contributors
- Dunsmore, J. (Creator), Duncan, E. (Creator), MacLennan, S. (Creator), N'Dow, J. (Creator), MacLennan, S. (Creator)
-
Data From Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer
- DOI
- 10.1002/bco2.411
- Publisher
- University of Aberdeen
- Links
- Date Made Available
- 01 July 2024
- Related Research Outputs
- Contributors
- Dunsmore, J. (Creator), Duncan, E. (Creator), MacLennan, S. (Creator), N'Dow, J. (Creator), Cornford, P. (Creator), Esperto, F. (Creator), Pavan, N. (Creator), Ribal, M. J. (Creator), Roobol, M. J. (Creator), Skolarus, T. A. (Creator), MacLennan, S. (Creator)
-
Data From Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer
- DOI
- 10.1002/bco2.411
- Publisher
- University of Aberdeen
- Links
- Date Made Available
- 01 July 2024
- Related Research Outputs
- Contributors
- Dunsmore, J. (Creator), Duncan, E. (Creator), MacLennan, S. (Creator), N'Dow, J. (Creator), Cornford, P. (Creator), Esperto, F. (Creator), Pavan, N. (Creator), Ribal, M. J. (Creator), Roobol, M. J. (Creator), Skolarus, T. A. (Creator), MacLennan, S. (Creator)
- Teaching
-
- Publications
-
Page 1 of 2 Results 1 to 100 of 124
CATHETER II, a randomised controlled trial comparing the clinical and cost effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long term catheters
BMJ OpenContributions to Journals: ArticlesWeb-based interventions for fear of cancer recurrence: a scoping review with a focus on suggestions for the development and evaluation of future interventions
PloS ONE, vol. 19, no. 11, e0312769Contributions to Journals: ArticlesPatient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial
RCOG World Congress 2024Contributions to Conferences: PostersPatient and health care professionals’ perception of weekly prophylactic catheter washout in adults living with long-term catheters: Qualitative Study of the CATHETER II Trial
The International Continence SocietyContributions to Conferences: PostersRCT comparing the clinical and cost effectiveness of various catheter washout policies
RCOG World Congress 2024Contributions to Conferences: PostersRCT comparing the clinical and cost effectiveness of various catheter washout policies
The International Continence SocietyContributions to Conferences: PostersTrends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
Scientific Reports, vol. 14, 19069Contributions to Journals: ArticlesSpecifying behavioural and strategy components of de-implementation efforts targeting low-value prescribing practices in secondary health care
Implementation Science Communications, vol. 5, no. 1, 88Contributions to Journals: ArticlesInfluences on Androgen Deprivation Therapy prescribing before surgery in high-risk prostate cancer
BJUI CompassContributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/bco2.411
Diabetes mellitus in sub-Saharan Africa during the COVID-19 pandemic: a scoping review
PloS ONE, vol. 19, no. 7, e0305112Contributions to Journals: ArticlesImpact of COVID-19 on diabetes mellitus outcomes and care in sub-Saharan Africa: A scoping review
Working Papers: Preprint Papers- [ONLINE] DOI: https://doi.org/10.1101/2024.04.10.24305598
Development of Prostate Cancer Typical Case Presentations and Their Usage in OPTIMA’s Guideline Based Decision Support Tool
39th Annual EAU CongressContributions to Conferences: AbstractsHow Can We Improve Patient-Clinician Communication for Men Diagnosed with Prostate Cancer?
European Urology Open Science, vol. 62, pp. 1-7Contributions to Journals: ArticlesStandardising Patient-Reported Outcomes in Prostate Cancer: Insights from the PIONEER Consortium
ISOQOL 2024Contributions to Conferences: AbstractsSurvivorship data in Prostate Cancer: Where are we and where do we need to be?
European Urology Open Science, vol. 59, pp. 27-29Contributions to Journals: Comments and DebatesThe role of Hospital-Based Cancer Registries (HBCRs) as information systems in the delivery of evidence-based integrated cancer care: a scoping review
Health System, vol. 13, no. 3, pp. 177-191Contributions to Journals: ArticlesEffectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review
Implementation Science Communications, vol. 4, 115Contributions to Journals: ArticlesIs there an association between intimate partner violence and the prevalence of cervical cancer screening in Jordan?
PloS ONE, vol. 18, no. 8, e0290678Contributions to Journals: ArticlesUnanswered questions in prostate cancer: Findings of an international multi-stakeholder consensus by the PIONEER Consortium
Nature reviews. Urology, vol. 20, pp. 494–501Contributions to Journals: ArticlesPD16-05 A SYSTEMATIC REVIEW TO EVALUATE PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR METASTATIC PROSTATE CANCER ACCORDING TO THE COSMIN METHODOLOGY: A PIONEER WP2 PROJECT
AUA 2023, pp. e491Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1097/JU.0000000000003271.05
How can we improve patient-clinician communication in men diagnosed with prostate cancer?: PA04
23rd International Meeting of the European Association of Urology NursesContributions to Conferences: AbstractsHow can we improve patient-clinician communication in men diagnosed with prostate cancer?
38th Annual EAU CongressContributions to Conferences: AbstractsTreatment burden in survivors of prostate and colorectal cancer:: a qualitative interview study.
BMJ Open, vol. 13, no. 3, e068997Contributions to Journals: ArticlesCost utility analysis of shockwave lithotripsy versus ureteroscopic stone treatment in adults
BJU International, vol. 131, no. 2, pp. 253-261Contributions to Journals: ArticlesHealth Status and Associated factors of middle-aged and Older Adult Cancer Survivors in India: Results from the Longitudinal Ageing Study in India
BMC Cancer, vol. 22, no. 1, 1087Contributions to Journals: ArticlesA Systematic Review to Evaluate Patient-Reported Outcomes Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-based Standard for the selection of Health Measurement INstruments (COSMIN) Methodology
Cancers, vol. 14, no. 20, 5120Contributions to Journals: ArticlesAn interpretative phenomenological analysis of the meaning of work to women living with breast cancer
Chronic Illness, vol. 18, no. 3, pp. 503-516Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/1742395320987883
- [ONLINE] View publication in Scopus
- [ONLINE] Accepted manuscript in Birkbeck institutional repository
Randomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long-term catheters: study protocol for the CATHETER II study
Trials, vol. 23, no. 1, 630Contributions to Journals: ArticlesSecondary Treatment for Men with Localized Prostate Cancer: a pooled analysis of PRIAS and ERSPC-Rotterdam data within the PIONEER data platform
Journal of Personalized Medicine, vol. 12, no. 5, 751Contributions to Journals: ArticlesUpdating and integrating core outcome sets for localised, locally advanced, metastatic and non-metastatic castration resistant prostate cancer: an update from the PIONEER Consortium
European Urology, vol. 81, no. 5, pp. 503-514Contributions to Journals: ArticlesDiagnostic and prognostic factors in patients with prostate cancer: a systematic review
BMJ Open, no. 12, e058267Contributions to Journals: ArticlesStandardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review
European Urology Oncology, vol. 5, no. 2, pp. 153-163Contributions to Journals: ArticlesShockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT
Health technology assessment (Winchester, England), vol. 26, no. 19, pp. 1-70Contributions to Journals: ArticlesOutcomes of importance to men with advanced prostate cancer:: PIONEER interview study
37th Annual Congress of the European Association of Urology, S1550Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/S0302-2838(22)01129-0
Patients’ and Health Care Professionals’ Expectations, Experience, and Perception of the Outcomes of Various Washout Policies in Preventing Catheter-associated Complications: Qualitative Study of the CATHETER II
European Urology Focus, vol. 8, no. 1, pp. 235-238Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.euf.2021.02.010
- [ONLINE] View publication in Scopus
Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries
European Urology Open Science, vol. 37, pp. 3-6Contributions to Journals: ArticlesWork-related Factors in the etiology of Symptoms of Post-traumatic Stress among First Responders: The Brazilian Firefighters Longitudinal Health Study (FLoHS)
Cadernos de Saúde Pública/Reports in Public Health, vol. 37, no. 9, e00135920Contributions to Journals: ArticlesEVALUATING PATIENT-REPORTED OUTCOMES MEASURES (PROMS) FOR LOCALISED PROSTATE CANCER: A SYSTEMATIC REVIEW USING THE CONSENSUS-BASED STANDARD FOR THE SELECTION OF HEALTH MEASUREMENT INSTRUMENTS (COSMIN) METHODOLOGY
Journal of Urology, vol. 206, no. S3, pp. E212-E212Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1097/JU.0000000000001989.07
What influences adherence to guidance for post-operative instillation of intravesical chemotherapy to bladder cancer patients?
BJU International, vol. 128, no. 2, pp. 225-235Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/bju.15336
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/16878/2/Dunsmore_et_al_BJUI_WhatInfluencesAdherence_AAM.pdf
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/16878/1/Dunsmore_etal_BJUI_What_influences_adherence_VOR.pdf
- [ONLINE] View publication in Scopus
Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial
European Urology, vol. 80, no. 1, pp. 46-54Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2021.02.044
TISU (Therepeutic Intervention for Stones in the Ureter): ESWL versus Ureteroscopy, a multicentre RCT
European Urology, vol. 79, no. S1, pp. S390-S390Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1016/S0302-2838(21)00660-6
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
BMJ Open, vol. 11, no. 2, e040531Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1136/bmjopen-2020-040531
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15928/1/1_s2.0_S0302283821000634_main.pdf
- [ONLINE] View publication in Scopus
Providing a Framework for Meaningful Patient Involvement in Clinical Practice Guideline Development and Implementation
European Urology Focus, vol. 7, no. 5, pp. 947-950Contributions to Journals: ArticlesThe Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer
European Urology FocusContributions to Journals: ArticlesIncreasing Engagement for Breast Cancer Screening and Treatment: The "ICANTREAT" Community of Expertise Initiative
Asian Pacific Journal of Cancer Prevention, vol. 21, no. 12, pp. 3655-3659Contributions to Journals: ArticlesPIONEER’s systematic review of outcomes in RCTs of men with non-metastatic castration resistant prostate cancer: Is there a need for a core outcome set?
35th Annual EAU CongressContributions to Conferences: AbstractsInitial steps of an online search tool development for diagnostic and prognostic factors in prostate cancer
12th European Multidisciplinary Congress on Urological Cancers 2020Contributions to Conferences: AbstractsPIONEER’s operational definitions:: Harmonising clinical characteristics and phenotypes data of prostate cancer patients
12th European Multidisciplinary Congress on Urological Cancers 2020Contributions to Conferences: AbstractsIdentifying the most appropriate instrument for patient reported outcome measure (PROMS) in patients with clinically localized prostate cancer
12th European Multidisciplinary Congress on Urological Cancers 2020Contributions to Conferences: AbstractsPIONEER consensus on clinician reported outcome measurements
12th European Multidisciplinary Congress on Urological Cancers 2020Contributions to Conferences: AbstractsEVOLVE: a framework for meaningful patient involvement in clinical practice guideline development and implementation
Cochrane Database of Systematic Reviews, vol. 9 Suppl 1, pp. 26Contributions to Journals: AbstractsNo turning back’ Psycho-oncology in the time of COVID-19: Insights from a survey of UK professionals
Psycho-Oncology, vol. 29, no. 9, pp. 1430-1435Contributions to Journals: ArticlesAuthor Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x)
Nature Reviews Urology, vol. 17, pp. 482Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1038/s41585-020-0355-3
- [ONLINE] View publication in Scopus
- [ONLINE] Springer Nature SharedIt link to author correction.
Benefits of an embedded qualitative study within clinical trials: Patient values and preferences
35th Annual EAU CongressContributions to Conferences: AbstractsIntroducing PIONEER: a project to harness big data in prostate cancer research
Nature reviews. Urology, vol. 17, pp. 351-362Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1038/s41585-020-0355-3
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/15415/1/Omar_NRU_AAM_In_principle.pdf
- [ONLINE] View publication in Scopus
. PIONEER’s systematic review of outcomes reported in effectiveness trials for interventions in locally advanced prostate cancer
11th European Multidisciplinary Congress on Urological CancersContributions to Conferences: AbstractsPIONEER’s update and integration of a localised prostate cancer core outcome set for effectiveness trials and a standard set for clinical practice
11th European Multidisciplinary Congress on Urological CancersContributions to Conferences: AbstractsEVOLVE: Designing a model of meaningful patient involvement in guideline development
European Urology Supplements, vol. 18, no. 1, pp. e2117Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/s1569-9056(19)31534-9
TISU: Extracorporeal shockwave lithotripsy, as first treatment option, compared with direct progression to ureteroscopic treatment, for ureteric stones: study protocol for a randomised controlled trial
Trials, vol. 19, no. 1, pp. 1-11Contributions to Journals: ArticlesCare pathways for the management of localised and locally advanced prostate cancer:: Experience of the EAU guidelines office
33rd Annual EAU Congress 2018, pp. PT075Contributions to Conferences: PostersCare pathways for the management of metastatic and castration-resistant prostate cancer in the era of novel therapeutic options:: Experience of the EAU guidelines office
33rd Annual EAU Congress 2018Contributions to Conferences: Posters“Throughout the cancer patient's journey, there ought to be a discussion about work”: The role of GPs in Scotland
Psycho-Oncology, vol. 27, no. 1, pp. 343-346Contributions to Journals: ArticlesThe relationship between social support and health-related quality of life in patients with antiphospholipid (hughes) syndrome
Modern Rheumatology , vol. 28, no. 1, pp. 147-155Contributions to Journals: ArticlesA core outcome set for localised prostate cancer effectiveness trials
BJU International, vol. 120, no. 5B, pp. E64-E79Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1111/bju.13854
- [ONLINE] View publication in Scopus
A core outcome set for localised prostate cancer effectiveness trials
BJU International, vol. 120, no. 5B, pp. E64-79Contributions to Journals: ArticlesChanging current practice in urological cancer care: Providing better information, advice and related support on work engagement
European Journal of Cancer Care, vol. 26, no. 5, e12756Contributions to Journals: ArticlesChanging Current Practice in Urology: Improving Guideline Development and Implementation Through Stakeholder Engagement
European Urology, vol. 72, no. 2, pp. 161-163Contributions to Journals: Editorials- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2017.02.008
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/10077/1/EURUROL_S_17_00216.pdf
The Relationship Between Social Support and Health-Related Quality of Life in Patients with Anti-Phospholipid Syndrome
Annual Meeting of the British-Society-for-Rheumatology, British-Health-Professionals-in-Rheumatology and the British-Society-for-Paediatric-and-Adolescent-Rheumatology (Rheumatology), pp. 110-110Contributions to Journals: AbstractsPatient-centered Care in Maternity Services: A Critical Appraisal and Synthesis of the Literature
Women's Health Issues, vol. 26, no. 1, pp. 100-109Contributions to Journals: ArticlesExploring the Role of General Practitioners in the Provision of Work-Related Advice, Information and Support to People with Cancer in Scotland: A Grounded Theory Study
NHS Scotland Research Conference 2015Contributions to Conferences: PostersSurgical management for localised penile cancer: [Cochrane Protocol]
Contributions to Journals: Registered ReportsAblative therapy for people with localised prostate cancer: a systematic review and economic evaluation
Health Technology Assessment, vol. 19, no. 49, pp. 1-524Contributions to Journals: ArticlesThe influences of nursing transformational leadership style on the quality of nurses’ working lives in Taiwan: a cross-sectional quantitative study
BMC Nursing, vol. 14, 33Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1186/s12912-015-0082-x
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4631/1/s12912_015_0082_x.pdf
Which type of indwelling urethral catheters should be used for short-term catheterisation in hospitalised adults?: Cochrane Systematic Review of the evidence
21rst Annual Scientific Meeting of the UK Continence SocietyContributions to Conferences: AbstractsSurgical management for localised penile cancer
Cochrane Database of Systematic Reviews, vol. 2015, no. 3, CD011533Contributions to Journals: Articles- [ONLINE] https://doi.org//10.1002/14651858.CD011533
- [ONLINE] DOI: https://doi.org/10.1002/14651858.CD011533
A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey
Trials, vol. 16, 76Contributions to Journals: Literature Reviews- [ONLINE] DOI: https://doi.org/10.1186/s13063-015-0598-0
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4460/1/s13063_015_0598_0.pdf
Antiphospholipid (Hughes) syndrome: description of population and health-related quality of life (HRQoL) using the SF-36
Lupus, vol. 24, no. 2, pp. 174-179Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/0961203314551809
Cancer Survivorship and Working Life
Contributions to Conferences: Papers- [ONLINE] DOI: https://doi.org/10.1111/j.1099-1611.2014.3697
An exploration of workplace social capital as an antecedent of occupational safety and health climate and outcomes in the Chinese education sector
International Archives of Occupational and Environmental Health , vol. 87, no. 5, pp. 515-526Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00420-013-0890-9
Cancer survivorship and sustainable working life
Contributions to Conferences: PapersCommunicating good care: A qualitative study of what people with urological cancer value in interactions with health care providers
European Journal of Oncology Nursing, vol. 18, no. 1, pp. 35-40Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.ejon.2013.09.009
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3113/1/Skea_2013.pdf
Time to act: The challenges of working during and after cancer, initiatives in research and practice
European Journal of Oncology Nursing, vol. 18, no. 1, pp. 1-2Contributions to Journals: Editorials- [ONLINE] DOI: https://doi.org/10.1016/j.ejon.2014.01.001
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/3186/1/Wells_2014.pdf
Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults
Cochrane Database of Systematic Reviews, no. 9, pp. CD004013Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1002/14651858.CD004013.pub4
- [ONLINE] View publication in Scopus
Determining information for inclusion in a decision-support intervention for clinical trial participation: A modified Delphi approach
Clinical Trials, vol. 10, no. 6, pp. 967-976Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1177/1740774513508339
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/4133/1/Gillies_2013.pdf
Determining items for inclusion in a decision support intervention for clinical trial participation: a modified Delphi approach
Contributions to Journals: Conference ArticlesSystematic Review of Adrenalectomy and Lymph Node Dissection in Locally Advanced Renal Cell Carcinoma
European Urology, vol. 64, no. 5, pp. 799-810Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2013.04.033
Menopause and work: an electronic survey of employees' attitudes in the UK
Maturitas, vol. 76, no. 2, pp. 155-159Contributions to Journals: ArticlesCritical outcomes in a Cochrane Systematic Review: patients’ perspective
Cochrane Database of Systematic Reviews, vol. 9, no. Suppl, P2.004Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1002/14651858.CD201300
The psychosocial work environment and mental health of teachers: a comparative study between the United Kingdom and Hong Kong
International Archives of Occupational and Environmental Health , vol. 86, no. 6, pp. 657-666Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00420-012-0799-8
Provision of cancer information as a "support for navigating the knowledge landscape": Findings from a critical interpretive literature synthesis
European Journal of Oncology Nursing, vol. 17, no. 3, pp. 360-369Contributions to Journals: ArticlesSystematic review and meta-analysis of the clinical effectiveness of bipolar compared to monopolar transurethral resection of the prostate
28th Annual EAU CongressContributions to Conferences: AbstractsSystematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer
European Urology, vol. 62, no. 6, pp. 1097-1117Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2012.07.028
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/2588/1/MacLennan_2013.pdf
Corrigendum to "systematic review of oncological outcomes following surgical management of localised renal cancer" [Eur Urol 2012;61:972-93]
European Urology, vol. 62, no. 1Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2012.04.003
- [ONLINE] View publication in Scopus
Systematic review of oncological outcomes following surgical management of localised renal cancer
European Urology, vol. 61, no. 5, pp. 972-993Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.eururo.2012.02.039
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/2550/1/MacLennan_2012.pdf
Occupational psychosocial health policies in Hong Kong schools: a review and exploration of key stakeholder perceptions
Health Policy, vol. 103, no. 2-3, pp. 266-275Contributions to Journals: Literature Reviews- [ONLINE] DOI: https://doi.org/10.1016/j.healthpol.2011.07.003
Enabling mutual helping?: Examining variable needs for facilitated peer support
Patient Education and Counseling, vol. 85, no. 2, pp. e120-e125Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.pec.2011.01.032
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstream/2164/2651/1/Skea_2011.pdf
Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines
World Journal of Urology, vol. 29, no. 3, pp. 291-301Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1007/s00345-011-0660-9
Concepts of information provision in cancer care: a critical interpretive synthesis of literature
Medical Encounter, vol. 25, no. 3, pp. 63Contributions to Journals: ArticlesSystematic review of the clinical effectiveness of surgical management for localised renal cell carcinoma
Commissioned by European Association of Urology. University of Aberdeen: Academic Urology UnitBooks and Reports: Commissioned ReportsQuality of life with urinary diversion
European Urology Supplements, vol. 9, no. 10, pp. 763-771Contributions to Journals: Articles- [ONLINE] DOI: https://doi.org/10.1016/j.eursup.2010.09.002